Ticker
ADVM

Price
14.14
Stock movement down
-0.52 (-3.55%)
Company name
Adverum Biotechnologies Inc
Exchange
(NASDAQ
,
Currency
USD
)
Sector
Healthcare >
Biotechnology
Market cap
141.02M
Ent value
180.61M
Price/Sales
-
Price/Book
0.68
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
-
Forward P/E
-
PEG
-
EPS growth
-11.44%
1 year return
76.75%
3 year return
-47.80%
5 year return
-22.81%
10 year return
-
Last updated: 2024-03-28

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

DIVIDENDS

ADVM does not pay dividends or no data was received

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E-
Price to OCF-
Price to FCF-
Price to EBITDA-
EV to EBITDA-

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales-
Price to Book0.68
EV to Sales-

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

FINANCIALS

Per share

Loading...
Per share data
Current share count9.97M
EPS (TTM)-15.70
FCF per share (TTM)-13.21

Income statement

Loading...
Income statement data
Revenue (TTM)0.00
Gross profit (TTM)0.00
Operating income (TTM)-157.61M
Net income (TTM)-156.21M
EPS (TTM)-15.70
EPS (1y forward)-12.70

Margins

Loading...
Margins data
Gross margin (TTM)-
Operating margin (TTM)-
Profit margin (TTM)-

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash84.43M
Net receivables155.00K
Total current assets213.24M
Goodwill0.00
Intangible assets0.00
Property, plant and equipment36.58M
Total assets332.36M
Accounts payable846.00K
Short/Current long term debt105.70M
Total current liabilities28.62M
Total liabilities124.03M
Shareholder's equity208.34M
Net tangible assets208.34M

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)-115.43M
Capital expenditures (TTM)15.98M
Free cash flow (TTM)-131.41M
Dividends paid (TTM)0.00

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity-74.98%
Return on Assets-47.00%
Return on Invested Capital-71.14%
Cash Return on Invested Capital-59.85%

iO Charts is a Seeking Alpha partner

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open14.63
Daily high14.81
Daily low13.83
Daily Volume110K
All-time high600.80
1y analyst estimate32.50
Beta0.75
EPS (TTM)-15.70
Dividend per share-
Ex-div date-
Next earnings date9 May 2024

Downside potential

Loading...
Downside potential data
ADVMS&P500
Current price drop from All-time high-97.65%-0.02%
Highest price drop-99.10%-56.47%
Date of highest drop27 Dec 20229 Mar 2009
Avg drop from high-84.28%-11.36%
Avg time to new high87 days13 days
Max time to new high2322 days1805 days

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

COMPANY DETAILS
ADVM (Adverum Biotechnologies Inc) company logo
Marketcap
141.02M
Marketcap category
Small-cap
Description
Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration and diabetic macular edema. Adverum Biotechnologies, Inc. has license and collaboration agreements with University of California; Cornell University; GenSight; Lexeo; and Virovek. The company was formerly known as Avalanche Biotechnologies, Inc. and changed its name to Adverum Biotechnologies, Inc. in May 2016. Adverum Biotechnologies, Inc. was incorporated in 2006 and is headquartered in Redwood City, California.
Employees
188
Investor relations
-
SEC filings
CEO
Leone D. Patterson
Country
USA
City
Redwood City
Stock type
Common stock
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

UNDERSTAND THE BUSINESS
Loading...